A citation-based method for searching scientific literature

Wei-Lei Yang, Zhen Lu, Robert C Bast. Expert Rev Mol Diagn 2017
Times Cited: 56







List of co-cited articles
281 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
17

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
Richard G Moore, D Scott McMeekin, Amy K Brown, Paul DiSilvestro, M Craig Miller, W Jeffrey Allard, Walter Gajewski, Robert Kurman, Robert C Bast, Steven J Skates. Gynecol Oncol 2009
477
14

Epidemiology of ovarian cancer: a review.
Brett M Reid, Jennifer B Permuth, Thomas A Sellers. Cancer Biol Med 2017
468
14

Epidemiology of epithelial ovarian cancer.
Penelope M Webb, Susan J Jordan. Best Pract Res Clin Obstet Gynaecol 2017
300
12


Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
731
10

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
491
10


Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.
György Sölétormos, Michael J Duffy, Suher Othman Abu Hassan, René H M Verheijen, Bengt Tholander, Robert C Bast, Katja N Gaarenstroom, Catharine M Sturgeon, Johannes M Bonfrer, Per Hyltoft Petersen,[...]. Int J Gynecol Cancer 2016
105
10

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
Richard G Moore, Amy K Brown, M Craig Miller, Steven Skates, W Jeffrey Allard, Thorsten Verch, Margaret Steinhoff, Geralyn Messerlian, Paul DiSilvestro, C O Granai,[...]. Gynecol Oncol 2008
422
8


Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
8

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Ignace Vergote, Claes G Tropé, Frédéric Amant, Gunnar B Kristensen, Tom Ehlen, Nick Johnson, René H M Verheijen, Maria E L van der Burg, Angel J Lacave, Pierluigi Benedetti Panici,[...]. N Engl J Med 2010
8

Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
Laura J Havrilesky, Clark M Whitehead, Jennifer M Rubatt, Robert L Cheek, John Groelke, Qin He, Douglas P Malinowski, Timothy J Fischer, Andrew Berchuck. Gynecol Oncol 2008
154
7

Reactivity of a monoclonal antibody with human ovarian carcinoma.
R C Bast, M Feeney, H Lazarus, L M Nadler, R B Colvin, R C Knapp. J Clin Invest 1981
7


Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
Daniel W Cramer, Robert C Bast, Christine D Berg, Eleftherios P Diamandis, Andrew K Godwin, Patricia Hartge, Anna E Lokshin, Karen H Lu, Martin W McIntosh, Gil Mor,[...]. Cancer Prev Res (Phila) 2011
196
7

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.
Karen H Lu, Steven Skates, Mary A Hernandez, Deepak Bedi, Therese Bevers, Leroy Leeds, Richard Moore, Cornelius Granai, Steven Harris, William Newland,[...]. Cancer 2013
74
7

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
R C Bast, T L Klug, E St John, E Jenison, J M Niloff, H Lazarus, R S Berkowitz, T Leavitt, C T Griffiths, L Parker,[...]. N Engl J Med 1983
7

Development of a multimarker assay for early detection of ovarian cancer.
Zoya Yurkovetsky, Steven Skates, Aleksey Lomakin, Brian Nolen, Trenton Pulsipher, Francesmary Modugno, Jeffrey Marks, Andrew Godwin, Elieser Gorelik, Ian Jacobs,[...]. J Clin Oncol 2010
177
7

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.
Usha Menon, Andy Ryan, Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Anne Dawnay, Mariam Habib, Sophia Apostolidou, Naveena Singh, Elizabeth Benjamin, Matthew Burnell,[...]. J Clin Oncol 2015
117
7


Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
Ronny Drapkin, Hans Henning von Horsten, Yafang Lin, Samuel C Mok, Christopher P Crum, William R Welch, Jonathan L Hecht. Cancer Res 2005
352
7



Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
Martin Köbel, Steve E Kalloger, Niki Boyd, Steven McKinney, Erika Mehl, Chana Palmer, Samuel Leung, Nathan J Bowen, Diana N Ionescu, Ashish Rajput,[...]. PLoS Med 2008
562
7

The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects.
Patrizia Bottoni, Roberto Scatena. Adv Exp Med Biol 2015
69
7

Diagnosis and Treatment of Ovarian Cancer.
Brian Orr, Robert P Edwards. Hematol Oncol Clin North Am 2018
63
7

Epithelial ovarian cancer.
Stephanie Lheureux, Charlie Gourley, Ignace Vergote, Amit M Oza. Lancet 2019
365
7

Ovarian Cancer: An Integrated Review.
Christine Stewart, Christine Ralyea, Suzy Lockwood. Semin Oncol Nurs 2019
138
7

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer.
Teresa Granato, Cecilia Midulla, Flavia Longo, Barbara Colaprisca, Luigi Frati, Emanuela Anastasi. Tumour Biol 2012
40
7

Cancer statistics, 2016.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2016
5

HE4: a new potential early biomarker for the recurrence of ovarian cancer.
Emanuela Anastasi, Giulia Giovanna Marchei, Valentina Viggiani, Giuseppina Gennarini, Luigi Frati, Maria Gabriella Reale. Tumour Biol 2010
116
5

Does HE4 have a role as biomarker in the recurrence of ovarian cancer?
Francesco Plotti, Stella Capriglione, Corrado Terranova, Roberto Montera, Alessia Aloisi, Patrizio Damiani, Ludovico Muzii, Giuseppe Scaletta, Pierluigi Benedetti-Panici, Roberto Angioli. Tumour Biol 2012
50
6

Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125.
Michèl Schummer, Charles Drescher, Robin Forrest, Shirley Gough, Jason Thorpe, Ingegerd Hellström, Karl Erik Hellström, Nicole Urban. Gynecol Oncol 2012
42
7

Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction.
Laura J Havrilesky, Gillian D Sanders, Shalini Kulasingam, Junzo P Chino, Andrew Berchuck, Jeffrey R Marks, Evan R Myers. Cancer 2011
25
12

Global cancer statistics, 2012.
Lindsey A Torre, Freddie Bray, Rebecca L Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, Ahmedin Jemal. CA Cancer J Clin 2015
5


HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.
T Van Gorp, I Cadron, E Despierre, A Daemen, K Leunen, F Amant, D Timmerman, B De Moor, I Vergote. Br J Cancer 2011
198
5


Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers.
Robert C Bast, Steven Skates, Anna Lokshin, Richard G Moore. Int J Gynecol Cancer 2012
45
6

Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective.
Martina Montagnana, Marco Benati, Elisa Danese. Ann Transl Med 2017
33
9


Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass.
Richard G Moore, M Craig Miller, Paul Disilvestro, Lisa M Landrum, Walter Gajewski, John J Ball, Steven J Skates. Obstet Gynecol 2011
154
5

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.
Brian Nolen, Liudmila Velikokhatnaya, Adele Marrangoni, Koen De Geest, Aleksey Lomakin, Robert C Bast, Anna Lokshin. Gynecol Oncol 2010
109
5

Detection and localization of surgically resectable cancers with a multi-analyte blood test.
Joshua D Cohen, Lu Li, Yuxuan Wang, Christopher Thoburn, Bahman Afsari, Ludmila Danilova, Christopher Douville, Ammar A Javed, Fay Wong, Austin Mattox,[...]. Science 2018
967
5

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
5


A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort.
Kathryn L Terry, Helena Schock, Renée T Fortner, Anika Hüsing, Raina N Fichorova, Hidemi S Yamamoto, Allison F Vitonis, Theron Johnson, Kim Overvad, Anne Tjønneland,[...]. Clin Cancer Res 2016
46
6

Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.
Wei-Lei Yang, Aleksandra Gentry-Maharaj, Archana Simmons, Andy Ryan, Evangelia Ourania Fourkala, Zhen Lu, Keith A Baggerly, Yang Zhao, Karen H Lu, David Bowtell,[...]. Clin Cancer Res 2017
30
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.